Top Banner
Grand Rounds Grand Rounds Michael Rubin, MD Michael Rubin, MD Department of Ophthalmology Department of Ophthalmology and Visual Science and Visual Science The University of Chicago The University of Chicago May 18, 2005 May 18, 2005
37
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: ROP

Grand RoundsGrand Rounds

Michael Rubin, MDMichael Rubin, MD

Department of Ophthalmology and Department of Ophthalmology and Visual ScienceVisual Science

The University of ChicagoThe University of ChicagoMay 18, 2005May 18, 2005

Page 2: ROP

Baby’s profileBaby’s profile

NICU Consultation for evaluation of girl:

• Birthdate: 12.24.2004• Gestational age: 24 weeks• Birth weight: 638 grams• Co-Morbidities: NEC• Mother: No PMH, first pregnancy and

delivery, no complications

Page 3: ROP

Left Eye 03/31/05Left Eye 03/31/05

Page 4: ROP

LE 04/15/05LE 04/15/05

Page 5: ROP
Page 6: ROP

Right Eye 03/31/05Right Eye 03/31/05

Page 7: ROP

Right Eye 04/14/05Right Eye 04/14/05

Page 8: ROP

ChronologyChronology

• 9-10 Weeks: First noted to have ROP bilaterally in posterior zone 2.

• 11-12 weeks: We first documented extra retinal growth, in both eyes, right worse than left. This appeared to be originating posterior to and clearly separated from the ridge, in discrete sectors superonasally (2-3 hours) and temporally (1-2 hours), and not entirely continuous within each sector. Posterior vessel changes were present but definitely did not meet plus criterion.

Page 9: ROP

Slow ProgressionSlow Progression

• We have followed this baby very closely over the month of April, and have documented slow progression in both eyes with the unusual pattern of multiple parallel arcs, as documented in the images. In some areas these arcs have become confluent with each other and with the ridge, but mostly they remain discrete.

• Circumferential extent has increased very slowly (with filling in of some of the gaps originally present)

Page 10: ROP

Prior to TreatmentPrior to Treatment

• At the time of treatment there was 6 hours total (4-5 continuous in the superonasal sector) for the RE, 4 hours total (3 continuous superonasal) for the LE of ERP.

• Posterior vessel changes were close to plus in the RE, definitely still less than plus in the LE.

• If the ridge was moving anteriorly in either eye, it was happening very slowly. It is my sense that the ridge wasn’t moving anteriorly.

• Most of zone 2 remained avascular in both eyes.

Page 11: ROP

DilemmaDilemma

• The ERP seems almost entirely to represent "popcorn" proliferation, and therefore questionably qualifiying for stage 3 status, yet progression has been continuing and this is clearly a high risk infant.

• She is close to but still a bit short of meeting strict treatment criteria in the right eye.

• Comfortably short of that point in the LE by Dr. Greenwald’s assessment.

• The required extent of laser application would be quite large. The situation is complicated by the fact that the baby's mother lives in Iowa and wants her transferred to a hospital in Dubuque ASAP; the NICU staff here have no problem with that provided her eye condition is judged to be acceptable for transfer by us.

Page 12: ROP

TreatmentTreatment

• Should we treat the RE now, and hold off on the LE pending further observation over a couple of weeks to confirm a positive response in the RE and continuing progression in the LE?

Page 13: ROP

Stage 1Stage 1

• Stage 1: A fine, thin demarcation line between the vascular and avascular region is present. This line has no height and no thickness.

Page 14: ROP

Stage 2Stage 2

• Stage 2: A broad, thick ridge clearly separates the vascular from the avascular retina.

• In zone 1, if there is any hint of pink or red in the ridge, this is an ominous sign. If there is any vessel engorgement, the disease should be considered threshold and treatment commenced within 72 hours.

• In zone 2, if there are no vascular changes and the ridge has no engorgement, the eye should be examined within 2 weeks. Prethreshold is defined as stage 2 with plus disease.

• In zone 3, examination every 3-4 weeks should be sufficient, unless of course there is any vascular tortuosity or straightening of the vascular arcades.

Page 15: ROP

Stage 3Stage 3

• Stage 3: The extraretinal fibrovascular proliferation (neovascularization) may be present on the ridge, on the posterior surface of the ridge or anteriorly toward the vitreous cavity. The neovascularization gives the ridge a velvety appearance, a ragged border.

• In zone 1, if there is any neovascularization, it is serious and requires treatment.

• In zone 2, prethreshold is defined as stage 3 without plus disease, or stage 3 with less than 5 contiguous or 8 noncontiguous hours. Threshold is stage 3 with at least 5 contiguous or 8 noncontiguous hours and plus disease.

• In zone 3, examination every 2-3 weeks should be sufficient, unless there is any vascular tortuosity or straightening of the vascular arcades.

Page 16: ROP

Stage 2 or 3?Stage 2 or 3?

• “Small isolated tufts of new vessels lying on the surface of the retina may be seen posterior to the ridge structure. Such lesions do not constitute the fibrovascular growth that is a necessary condition for stage 3.”

Committee for Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-4.

Page 17: ROP

Stage 4 and 5Stage 4 and 5

– Stage 4: This stage is a subtotal retinal detachment beginning at the ridge. The retina is pulled anteriorly into the vitreous by the fibrovascular ridge.

• Stage 4A does not involve the fovea. • Stage 4B involves the fovea.

– Stage 5: This stage is a total retinal detachment in the shape of a funnel.

• Stage 5A is an open funnel. • Stage 5B is a closed funnel.

Page 18: ROP

PlusPlus

• Plus disease is defined as dilation and tortuosity of the peripheral retinal vessels, iris vascular engorgement, pupillary rigidity, and vitreous haze, which are part of the subclassification given to the above stages.

Page 19: ROP

Popcorn StudyPopcorn Study

• Significance of isolated neovascular tufts ("Popcorn") in retinopathy of prematurity

• David K. Wallace MD, Jan A. Kylstra MD, David B. Greenman BA, and Sharon F. Freedman MDb

Page 20: ROP

Study DesignStudy Design

• The significance of isolated neovascular tufts ("popcorn") occurring in association with stage 2 retinopathy of prematurity (ROP) has not been studied.

• The authors retrospectively reviewed the clinical courses and outcomes of all patients with zone II, stage 2 ROP with popcorn examined over the past 3 years at one institution.

• Eyes with zone I disease, plus disease, or stage 3 at the initial appearance of popcorn were excluded.

• The study group was compared with a control group of patients of similar birth weight and gestational age with zone II, stage 2 ROP without popcorn.

Page 21: ROP

ResultsResults

• Popcorn first appeared at a mean age of 36.4 (±2.2) weeks after conception in 26 patients.

• Of these, 17 patients (65%) progressed to stage 3, 10 (38%) had plus disease, 6 (23%) reached threshold, and 9 (35%) required laser treatment.

• Of 19 control patients, 4 (21%) progressed to stage 3, 1 (5%) had plus disease, 1 (5%) reached threshold, and 1 (5%) required laser treatment.

• The popcorn group had a significantly higher incidence of progression to stage 3 (p<0.005), plus disease (p<0.025), and laser treatment (p<0.025). All eyes of both groups had complete regression of disease.

Page 22: ROP

Conclusion of StudyConclusion of Study

• The presence of popcorn significantly increases the risk that an eye with zone II, stage 2 ROP will progress to stage 3, develop plus disease, and require laser treatment. Patients with popcorn and coexistent mild vascular dilation or tortuosity insufficient for plus disease are at particularly high risk for disease progression.

Page 23: ROP

PopcornPopcorn

• Small isolated tufts of new blood vessels, commonly referred to as “popcorn,” may be seen posterior to a stage 2 ridge.

• Although they represent extraretinal fibrovascular proliferation, they do not constitute the fibrovascular growth that is required to diagnose stage 3 ROP.

Page 24: ROP

Study DefinitionStudy Definition

• Study defined popcorn as one or more areas of isolated tufts of fibrovascular tissue located posterior to, and not contiguous with, a stage 2 ridge.

Page 25: ROP

Regression??Regression??

• Significance of popcorn is not well known, although traditionally it has been thought of as a sign of disease regression, developing as a stage 2 ridge advances anteriorly.

Page 26: ROP

……or Progression?or Progression?

• It has been reported that isolated tufts of neovascular tissue can occur early or late in the course of active ROP and in association with either progressing or regressing disease.

Page 27: ROP

CharacteristicsCharacteristics

• Popcorn can be single or multiple, in one or more quadrants, and located posterior to the ridge, or a great distance from it.

Page 28: ROP

Predictor of Progression?Predictor of Progression?

• It is now believed that the presence of popcorn represents a predictor of disease progression.

• We know that the major prognostic factors in ROP are zone, plus disease, and stage.

Page 29: ROP

? 2 types of popcorn? 2 types of popcorn

• 1. Assoicated with an increased risk of disease progression

• 2. One that occurs later in the disease process as an advancing stage 2 ridge leaves behind benign tufts of neovascular tissue.

Page 30: ROP

Aggressive?Aggressive?

• In this study, all patients in the control and popcorn group regressed prior to indication for treatment.

• Is it the case that patients in whom popcorn develops before state 3 may have a more benign, slowly progressive form of ROP?

Page 31: ROP

Application to PracticeApplication to Practice

• Likely 2 forms of “Popcorn.”

1. Early Form: Follow closely, will likely lead to definitive stage 3 disease.

2. Late Form: May be sign of regression, as the ridge is scooting anteriorly.

3. Do we need to revamp the classification system? Any suggestions?

Page 32: ROP

Patient visit pricingPatient visit pricing

Initial ROP Consult:

Billed: $300 Collected: $60

Follow up ROP visits (per visit):

Billed: $80 Collected: $25

Billed: $2080 Collected: $624

Page 33: ROP

Laser CostLaser Cost

• Laser Cost

Right Eye: $2200 Collected: $350

Left Eye: $2200 Collected: $350

Page 34: ROP

Inpatient CostsInpatient Costs

• NICU Stay (per day):

Billed: $3343.00

Medicaid Pays: $2005.80

Step Down (per day):

Billed: $2389.00

Medicaid Pays: $1433.40

Page 35: ROP

Total CostsTotal Costs

• Total Inpatient Costs:

Billed: $491,890

Collected: $295,134

Average NICU stay costs: $58,000

Page 36: ROP

References References • Ashton N: Oxygen and the retinal blood vessels. Trans Ophthalmol Soc U K 1980 Sep; 100(3): 359-62. • Campbell K: Intensive oxygen therapy as a possible cause for retrolental fibroplasia. A clinical approach. Med J

Austr 1951; 2: 48-50. • Cryotherapy for Retinopathy of Prematurity Cooperative Group: Multicenter trial of cryotherapy for retinopathy of

prematurity. One- year outcome--structure and function. Arch Ophthalmol 1990 Oct; 108(10): 1408-16. • Fielder AR, Shaw DE, Robinson J, Ng YK: Natural history of retinopathy of prematurity: a prospective study. Eye

1992; 6 ( Pt 3): 233-42]. • Kretzer FL, Hittner HM: Retinopathy of prematurity: clinical implications of retinal development. Arch Dis Child

1988 Oct; 63(10 Spec No): 1151-67. • Laser ROP Study Group: Laser therapy for retinopathy of prematurity. Arch Ophthalmol 1994 Feb; 112(2): 154-6. • Palmer EA, Flynn TJ, Hardy RJ: The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence

and early course of retinopathy of prematurity. Ophthalmology 1991; 98: 1628-40. • Phelps DL: Retinopathy of prematurity: an estimate of vision loss in the United States--1979. Pediatrics 1981 Jun;

67(6): 924-5. • Repka MX, Hardy RJ, Phelps DL, Summers CG: Surfactant prophylaxis and retinopathy of prematurity. Arch

Ophthalmol 1993 May; 111(5): 618-20. • Schaffer DB, Palmer EA, Plotsky DF, et al: Prognostic factors in the natural course of retinopathy of prematurity.

The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1993 Feb; 100(2): 230-7. • STOP-ROP: Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a

randomized, controlled trial. I: primary outcomes. Pediatrics 2000 Feb; 105(2): 295-310. • Terry TL: Extreme prematurity and fibroplastic overgrowth of persistent vascular sheath behind each crystalline

lens I. Preliminary report. Am J Ophthalmol 1942; 25: 203-4. • The Committee for the Classification of Retinopathy of Prematurity: An international classification of retinopathy of

prematurity. Arch Ophthalmol 1984 Aug; 102(8): 1130-4.

Page 37: ROP